Fred Hutchinson

ATLANTA — Transplant-associated thrombotic microangiopathy may be a final common pathway for several disorders with different pathophysiologic mechanisms, according to a retrospective cohort analysis presented at the ASH Annual Meeting and Exposition.

Controlled feeding studies may help researchers better understand the effects of diet on the gut microbial structure in association with risk for disease, according to a presentation at The Human Microbiome: Emerging Themes at the Horizon of the 21st Century.

CD19-specific chimeric antigen receptor-modified T-cell therapy induced durable molecular remissions in patients with high-risk chronic lymphocytic leukemia who had previous treatment failure with ibrutinib, according to results from a phase 1/phase 2 study published in Journal of Clinical Oncology.